Cargando…

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy

BACKGROUND: In HIV-infected individuals, mechanisms underlying unsatisfactory immune recovery during effective combination antiretroviral therapy (cART) have yet to be fully understood. We investigated whether polymorphism of genes encoding immune-regulating molecules, such as killer immunoglobulin-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soria, Alessandro, Guerini, Franca Rosa, Bandera, Alessandra, Bolognesi, Elisabetta, Uglietti, Alessia, Fusco, Caterina, Zucchi, Patrizia, Maserati, Renato, Rizzardini, Giuliano, Clerici, Mario, Gori, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207876/ https://www.ncbi.nlm.nih.gov/pubmed/22073315 http://dx.doi.org/10.1371/journal.pone.0027349

Ejemplares similares

A role for activatory KIR/HLA complexes in HIV-associated Kaposi’s sarcoma development
por: Agostini, Simone, et al.
Publicado: (2011)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
por: Guerini, Franca R, et al.
Publicado: (2012)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil
por: Elpidio, Laise Nayana Sala, et al.
Publicado: (2022)

Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial
por: Soria, Alessandro, et al.
Publicado: (2015)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Editorial: Role of HLA and KIR in Viral Infections
por: de Wit, Jelle, et al.
Publicado: (2016)

The role of KIR and HLA interactions in pregnancy complications
por: Colucci, Francesco
Publicado: (2017)

KIR and HLA-C genes in male infertility
por: Wilczyńska, Karolina, et al.
Publicado: (2020)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

HLA Allele Frequencies and Association with Severity of COVID-19 Infection in Northern Italian Patients
por: Guerini, Franca Rosa, et al.
Publicado: (2022)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

VDR Gene Single Nucleotide Polymorphisms and Autoimmunity: A Narrative Review
por: Agliardi, Cristina, et al.
Publicado: (2023)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
por: Jarduli, Luciana Ribeiro, et al.
Publicado: (2013)

Editorial: HLA and KIR Diversity and Polymorphisms: Emerging Concepts
por: Maiers, Martin, et al.
Publicado: (2021)

KIR-HLA gene diversities and susceptibility to lung cancer
por: Hematian Larki, Marjan, et al.
Publicado: (2022)

Correlations between atazanavir C(trough )and hyperbilirubinemia: a case report
por: Uglietti, Alessia, et al.
Publicado: (2009)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Understanding how combinations of HLA and KIR genes influence disease
por: Rajagopalan, Sumati, et al.
Publicado: (2005)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
por: Cariani, Elisabetta, et al.
Publicado: (2013)

The impact of KIR/HLA genes on the risk of developing multibacillary leprosy
por: Alves, Hugo Vicentin, et al.
Publicado: (2019)

ERAP, KIR, and HLA-C Profile in Recurrent Implantation Failure
por: Piekarska, Karolina, et al.
Publicado: (2021)

Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients
por: Sabbatini, Francesca, et al.
Publicado: (2010)

Distribution of HLA-A, -B, and -C Alleles and HLA/KIR Combinations in Han Population in China
por: Shen, Yunsong, et al.
Publicado: (2014)

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery
por: Bandera, Alessandra, et al.
Publicado: (2018)

Remarkably Low KIR and HLA Diversity in Amerindians Reveals Signatures of Strong Purifying Selection Shaping the Centromeric KIR Region
por: de Brito Vargas, Luciana, et al.
Publicado: (2021)

Fully Immunocompetent CD8+ T Lymphocytes Are Present in Autologous Haematopoietic Stem Cell Transplantation Recipients Despite an Ineffectual T-Helper Response
por: Bandera, Alessandra, et al.
Publicado: (2008)

KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections
por: Qi, Ying, et al.
Publicado: (2006)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
por: Thobakgale, CF, et al.
Publicado: (2012)

Analysis of the expression of KIR and HLA-Cw in a Northeast Han population
por: HAN, YU, et al.
Publicado: (2013)

Impact of multiplicity of functional KIR-HLA compound genotypes on hepatocellular carcinoma
por: Tanimine, Naoki, et al.
Publicado: (2015)

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
por: Umemura, Takeji, et al.
Publicado: (2019)

Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data
por: Song, Li, et al.
Publicado: (2023)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

HLA alleles modulate EBV viral load in multiple sclerosis
por: Agostini, Simone, et al.
Publicado: (2018)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO
por: Higuchi, Osamu, et al.
Publicado: (2016)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ue2rltndf0b23r9t28mgcf651h